Holding(s) in Company

Cambridge Antibody Tech Group PLC 21 October 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Cambridge Antibody Technology 2) Name of shareholder having a major interest Goldman Sachs Group, Inc 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 1,089,604 shares - Goldman Sachs Securities (Nominees) Limited - non beneficial 116,200 shares - The Depositary Trust Company, New York - non beneficial 100 shares - Depositary Trust Company - as in 2) above 1,400 shares - GSSN - as in 2) above 334,864 shares - Goldman Sachs International (CREPTEMP) - as in 2) above 128,400 shares - JB Were Managed Funds Limited - non beneficial 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them 1,089,604 shares - Goldman Sachs Securities (Nominees) Limited 116,200 shares - The Depositary Trust Company, New York 100 shares - Depositary Trust Company 1,400 shares - GSSN 334,864 shares - Goldman Sachs International (CREPTEMP) 128,400 shares - JB Were Managed Funds Limited 5) Number of shares/amount of stock acquired Not known 6) Percentage of issued class N/A 7) Number of shares/amount of stock disposed Not known 8) Percentage of issued class N/A 9) Class of security Ordinary 10 pence shares 10) Date of transaction Not known 11) Date company informed 21 October 2004 12) Total holding following this notification 1,670,568 ordinary 10 pence shares 13) Total percentage holding of issued class following this notification 4.06% 14) Any additional information 15) Name of contact and telephone number for queries Justin Hoskins, 01223 898589 16) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of notification 21 October 2004 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings